Table 6.

The variety of current COVID-19 treatments.

Antivirals	Darunavir, Favipiravir, Opinavir/Ritonavir, Oseltamivir, Remdesivir, Ribavirin, Umifenovir
Anti-cytokine/anti-inflammatories	Anakinra, canakinumab, eculizumab, sarilumab, tocilizumab
Anti-coagulopathy drugs	Heparin, low-molecular-weight heparins, dipyridamole
Antiparasitics	Ivermectin, nitazoxanide
Colchicine
Corticosteroids
Cyclosporine
Immunomodulatory/antivirals	Azithromycin, Auranofin, Hydroxychloroquine/Chloroquine
Interferons	Type I IFNs (IFN-α and IFN-β)
Janus kinase (JAK) inhibitors	Baricitinib, ruxolitinib, tofacitinib
Specific and non-specific intravenous immune globulins